CONTACTS
SUBJECTS
VA Prescribe Atorvastin 10 MG Trial 4 Weeks Evaluate Side Effects In
1303 -
1303 - ..
1304 - Summary/Objective
1305 -
130501 - Follow up ref SDS 45 0000. ref SDS 44 0000.
130502 -
130503 -
130504 -
130505 -
130506 -
130508 - ..
1306 -
1307 -
1308 - Background
1309 -
1310 -
131001 - Lab on 131015, showing cholesterol remained high, 131015 0724,
131002 - ref SDS 38 BE6O, conflict with increased exercise and weight loss,
131003 - discussed in the letter to the medical team yesterday on 131016 1632.
131004 - ref SDS 39 IW57
131006 - ..
131007 - On 131017 1000 VA medical chart Progress Notes assessment report
131008 - patient status CAD stable, asymptomatic. hyperlipidemia not
131009 - controlled. ref SDS 40 T24N
131011 - ..
131012 - On 131017 1000 Doctor Egan proposed referring patient for clinical
131013 - trial to reduce cholesterol with new "targeted" drugs. ref SDS 40 179N
131015 - ..
131016 - On 131017 1000 VA medical chart Progress Notes assessment report
131017 - patient status hyperlipidemia not controlled, ref SDS 40 PSXT; Doctor
131018 - Egan makes referral to SF VA Medical Center for consult on
131019 - participation clinical trials, ref SDS 40 EU9F, with experimental
131020 - agents such as AMG 145 and REGN 727 to resolve multiple statin
131021 - intolerances. ref SDS 40 CN4H
131023 - ..
131024 - On 131103 received letter from VA SF Medical Center scheduling meeting
131025 - on 131121 1000, to consider clinical trial for lowering cholesteral.
131026 - ref SDS 41 YT4N
131027 -
131028 - Thursday November 21, 2013 1000 METAB-FELLOW-THRUSDAY Clinic
131030 - ..
131031 - On 131112 New York Times published several articles reporting that the
131032 - day before on 131113, American Heart Association published new
131033 - guidelines for treating CAD patients that expand use of statin
131034 - medication regardless of cholesterol levels, ref SDS 42 0001, and
131035 - further raise the LDL 70 to LDL 190, as a target for cardiovascular
131036 - risk. ref SDS 42 CW6H
131038 - ..
131039 - On 131114 New York Times published several articles reporting that the
131040 - day before on 131113, American Heart Association published new
131041 - guidelines for treating CAD patients. ref SDS 43 SH6G
131043 - ..
131044 - On 131121 1000 meeting with Doctor Diana Alba, Va San Francisco
131045 - Medical Center prescribes Atorvastatin 10 MG 4 weeks. ref SDS 44 HY6O
131047 - ..
131048 - On 131121 1000 at 1125 meeting with Karen and Doctor Shunk, Va San
131049 - Francisco Medical Center seemed to support Doctor Alba's prescription
131050 - for Atorvastatin 10 MG 4 weeks; further suggested trying Chia seeds to
131051 - lower cholesterol without medication. ref SDS 44 MS7G
131053 - ..
131054 - On 131125 0005 letter to Karen submits understandings from meetings at
131055 - VA on 131121 with Doctor Alba, ref SDS 45 UK43, and requests that
131056 - Karen submit to Doctor Alba. ref SDS 45 UK5J Presented patient
131057 - history showing increased exercise lowered cholesterol, but later
131058 - cholesterol rose even while increasing exercise. ref SDS 45 UK6R
131059 - Notified VA taking Atorvastatin 40 mg on 4-week trial. ref SDS 45 UK49
131060 -
131061 -
131062 -
131063 -
131065 - ..
1311 -
1312 -
1313 - Progress
1314 -
131401 - Hyperlipidemia Not Controlled Cholesterol Elevated Despite Exercise
131402 - Cholesterol Elevated Despite Exercise Discuss Clinical Trial
131403 - Clinical Trial Considered Lower Cholesterol Without Statin Drugs
131404 -
131405 - Follow up ref SDS 45 HY6O, ref SDS 44 HY6O.
131406 -
131407 - Received letter from Doctor Alba saying...
131408 -
131409 - 1. Subject: RE: VA Meeting 21 Nov 2013, Clinical Trials Non-statin Solutions
131410 - Date: 2013-12-10 12:21
131417 - ..
131418 - 2. Just following up with you to make sure that you recevied the
131419 - Atorvastatin. Any issues?
131421 - ..
131422 - Doctor Alba follows up her letter planning another meeting at VA on
131423 - 131219, received on 131125 0005. ref SDS 45 I67O
131424 -
131425 - [On 131216 0028 letter to Doctor Alba and medical team
131426 - submits pending issues to discuss during meeting on 131219,
131427 - ref SDS 46 8N50, and lists TG/HDL-C ratio and LDL-P issues.
131428 - ref SDS 46 6T49
131430 - ..
131431 - Letter from Doctor Alba concludes...
131432 -
131433 - 3. Best,
131434 -
131435 -
131440 -
131441 -
131442 -
131443 -
131444 -
131445 -
131446 -
131447 -
131448 -
1315 -